Kowa Company, Ltd.

This study tested the safety and effectiveness of a new extended-release pill (K-877 ER) for lowering high triglycerides, a type of fat in the blood, over one year. It involved 121 adults with dyslipidemia who took the pill daily, with the dose adjusted if needed. The goal was to…

This study tested a new, longer-acting version of an existing cholesterol medication called pemafibrate. It involved 60 adults with high triglycerides and cholesterol to see if the new pill worked as well as the standard one. Researchers compared how the body processed the drug a…

This study tested a new drug called Pemafibrate (K-877) for people with high cholesterol who cannot tolerate standard statin medications due to side effects. In this 12-week trial, 71 participants received either the new drug or a placebo pill to see if it safely lowered their 'b…